|
ATE9716T1
(de)
|
1980-02-27 |
1984-10-15 |
Tate & Lyle Public Limited Company |
Kristalline glukose und verfahren zu deren herstellung.
|
|
US4816445A
(en)
|
1984-06-21 |
1989-03-28 |
Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo |
Crystalline alpha-maltose
|
|
JP2518646B2
(ja)
|
1987-05-29 |
1996-07-24 |
株式会社 林原生物化学研究所 |
マルト−ス粉末の製造方法
|
|
US5133974A
(en)
|
1989-05-05 |
1992-07-28 |
Kv Pharmaceutical Company |
Extended release pharmaceutical formulations
|
|
DE69012458T3
(de)
|
1989-05-31 |
2000-01-20 |
Fisons Plc, Ipswich |
Medikament und Inhalationsvorrichtung dafür.
|
|
IL95590A
(en)
|
1989-09-08 |
1996-06-18 |
Glaxo Group Ltd |
Medicinal preparations containing Salmetrol and Pluticasone Propionate
|
|
ATE92762T1
(de)
|
1989-09-08 |
1993-08-15 |
Glaxo Group Ltd |
Medikamente.
|
|
SE8903914D0
(sv)
|
1989-11-22 |
1989-11-22 |
Draco Ab |
Oral composition for the treatment of inflammatory bowel diseases
|
|
US6536427B2
(en)
*
|
1990-03-02 |
2003-03-25 |
Glaxo Group Limited |
Inhalation device
|
|
US5178866A
(en)
|
1990-03-23 |
1993-01-12 |
Alza Corporation |
Dosage form for delivering drug to the intestine
|
|
WO1992001730A1
(en)
*
|
1990-07-26 |
1992-02-06 |
Monsanto Company |
Novel polyamines and method for preparation thereof
|
|
GR1001529B
(el)
|
1990-09-07 |
1994-03-31 |
Elmuquimica Farm Sl |
Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
|
|
US5434304A
(en)
|
1990-09-26 |
1995-07-18 |
Aktiebolaget Astra |
Process for preparing formoterol and related compounds
|
|
AU650953B2
(en)
|
1991-03-21 |
1994-07-07 |
Novartis Ag |
Inhaler
|
|
US5795564A
(en)
|
1991-04-05 |
1998-08-18 |
Sepracor, Inc. |
Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
|
|
US6866839B2
(en)
|
1991-04-05 |
2005-03-15 |
Sepracor Inc. |
Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
|
|
ATE246497T1
(de)
|
1991-06-10 |
2003-08-15 |
Schering Corp |
Fluorchlorkohlenwasserstoffreie aerosolformulierungen
|
|
IT1250691B
(it)
|
1991-07-22 |
1995-04-21 |
Giancarlo Santus |
Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
|
|
CZ288032B6
(cs)
|
1991-12-18 |
2001-04-11 |
Aktiebolaget Astra |
Farmaceutický prostředek pro podání inhalací
|
|
GB9213874D0
(en)
|
1992-06-30 |
1992-08-12 |
Fisons Plc |
Process to novel medicament form
|
|
GB9306703D0
(en)
|
1993-03-31 |
1993-05-26 |
Fisons Plc |
Inhalation device
|
|
WO1994022899A1
(de)
|
1993-04-02 |
1994-10-13 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Neue prednisolonderivate
|
|
IL111194A
(en)
|
1993-10-08 |
1998-02-08 |
Fisons Plc |
Process for the production of drug patramulations
|
|
DE19541689A1
(de)
*
|
1994-11-14 |
1996-05-15 |
Byk Gulden Lomberg Chem Fab |
Kombinationsarzneimittel
|
|
US5811388A
(en)
|
1995-06-07 |
1998-09-22 |
Cibus Pharmaceutical, Inc. |
Delivery of drugs to the lower GI tract
|
|
EP0833622B8
(en)
|
1995-06-12 |
2005-10-12 |
G.D. Searle & Co. |
Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
|
|
EP0852498A1
(en)
|
1995-09-26 |
1998-07-15 |
Takeda Chemical Industries, Ltd. |
Phosphorylamides, their preparation and use
|
|
DE19635498A1
(de)
|
1996-09-03 |
1998-03-26 |
Byk Gulden Lomberg Chem Fab |
Verfahren zur Epimerenanreicherung
|
|
US6599927B2
(en)
|
1996-10-11 |
2003-07-29 |
Astrazeneca Ab |
Use of an H+, K+-ATPase inhibitor in the treatment of Widal's Syndrome
|
|
SE9603725D0
(sv)
|
1996-10-11 |
1996-10-11 |
Astra Ab |
New teatment
|
|
FR2754712B1
(fr)
|
1996-10-17 |
1999-09-03 |
Merck Sharp Dohme Chibret Lab |
Compositions ophtalmiques
|
|
ES2178015T3
(es)
|
1996-11-11 |
2002-12-16 |
Sepracor Inc |
Procedimiento de preparacion de isomeros de formoterol opticamente puros.
|
|
US6040344A
(en)
|
1996-11-11 |
2000-03-21 |
Sepracor Inc. |
Formoterol process
|
|
US6613795B2
(en)
|
1996-11-11 |
2003-09-02 |
Christian Noe |
Enantiomerically pure basic arylcycloalkylhydroxycarboxylic esters, processes for their preparation and their use in medicaments
|
|
SE9700135D0
(sv)
|
1997-01-20 |
1997-01-20 |
Astra Ab |
New formulation
|
|
US20020111495A1
(en)
*
|
1997-04-04 |
2002-08-15 |
Pfizer Inc. |
Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
|
|
US6120752A
(en)
|
1997-05-21 |
2000-09-19 |
3M Innovative Properties Company |
Medicinal aerosol products containing formulations of ciclesonide and related steroids
|
|
GB2329939A
(en)
|
1997-06-26 |
1999-04-07 |
Glaxo Group Ltd |
Self-lubricating valve stem for aerosol containers
|
|
US6470894B2
(en)
|
1997-09-19 |
2002-10-29 |
Thione International, Inc. |
Glutathione, green tea, grape seed extract to neutralize tobacco free radicals
|
|
EP1021172B1
(en)
|
1997-10-08 |
2002-04-10 |
Sepracor, Inc. |
Dosage form for aerosol administration
|
|
SE9704186D0
(sv)
|
1997-11-14 |
1997-11-14 |
Astra Ab |
New composition of matter
|
|
AU1507199A
(en)
|
1997-12-15 |
1999-07-05 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel pyrimidine-5-carboxamide derivatives
|
|
SE9801368D0
(sv)
|
1998-04-20 |
1998-04-20 |
Astra Ab |
New use
|
|
TWI243687B
(en)
|
1998-04-21 |
2005-11-21 |
Teijin Ltd |
Pharmaceutical composition for application to mucosa
|
|
US6241969B1
(en)
|
1998-06-26 |
2001-06-05 |
Elan Corporation Plc |
Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
|
|
NZ509328A
(en)
|
1998-07-24 |
2002-11-26 |
Jago Res A |
Medicinal aerosol formulations
|
|
ATE234604T1
(de)
*
|
1998-08-04 |
2003-04-15 |
Jago Res Ag |
Medizinische aerosolformulierungen
|
|
EA005377B1
(ru)
|
1998-09-23 |
2005-02-24 |
Алтана Фарма Аг |
ТЕТРАГИДРОИМИДАЗО [1,2-h][1,7] НАФТИРИДИНОВЫЕ СОЕДИНЕНИЯ
|
|
CA2347856C
(en)
*
|
1998-11-13 |
2009-02-17 |
Jago Research Ag |
Dry powder for inhalation
|
|
US6352152B1
(en)
|
1998-12-18 |
2002-03-05 |
Smithkline Beecham Corporation |
Method and package for storing a pressurized container containing a drug
|
|
US6124268A
(en)
|
1999-02-17 |
2000-09-26 |
Natreon Inc. |
Natural antioxidant compositions, method for obtaining same and cosmetic, pharmaceutical and nutritional formulations thereof
|
|
JP2001048807A
(ja)
|
1999-08-04 |
2001-02-20 |
Wakamoto Pharmaceut Co Ltd |
難溶性薬物を水に溶解してなる製剤
|
|
DE19947234A1
(de)
|
1999-09-30 |
2001-04-05 |
Asta Medica Ag |
Neue Kombination von Loteprednol und Antihistaminika
|
|
AR026073A1
(es)
|
1999-10-20 |
2002-12-26 |
Nycomed Gmbh |
Composicion farmaceutica acuosa que contiene ciclesonida
|
|
AR026072A1
(es)
|
1999-10-20 |
2002-12-26 |
Nycomed Gmbh |
Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
|
|
GB0002336D0
(en)
|
2000-02-01 |
2000-03-22 |
Glaxo Group Ltd |
Medicaments
|
|
GB0009607D0
(en)
|
2000-04-18 |
2000-06-07 |
Glaxo Group Ltd |
Medical compositions
|
|
GB0012261D0
(en)
|
2000-05-19 |
2000-07-12 |
Astrazeneca Ab |
Novel process
|
|
GB0015043D0
(en)
|
2000-06-21 |
2000-08-09 |
Glaxo Group Ltd |
Medicament dispenser
|
|
FI20002177A0
(fi)
|
2000-10-02 |
2000-10-02 |
Orion Yhtymae Oyj |
Uusi yhdistelmä astman hoitoon
|
|
DE10062712A1
(de)
|
2000-12-15 |
2002-06-20 |
Boehringer Ingelheim Pharma |
Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
|
|
US20020183292A1
(en)
|
2000-10-31 |
2002-12-05 |
Michel Pairet |
Pharmaceutical compositions based on anticholinergics and corticosteroids
|
|
AU2002227123A1
(en)
|
2000-11-07 |
2002-05-21 |
Merck And Co., Inc. |
Method of treatment with a combination of a pde4 inhibitor and a leukotriene antagonist
|
|
AU2002222304B2
(en)
|
2000-12-22 |
2004-03-18 |
Glaxo Group Limited |
Metered dose inhaler for salmeterol xinafoate
|
|
WO2002062317A2
(en)
*
|
2001-02-06 |
2002-08-15 |
Innovata Biomed Limited |
Bimodal dry powder formulation for inhalation
|
|
US20030055026A1
(en)
*
|
2001-04-17 |
2003-03-20 |
Dey L.P. |
Formoterol/steroid bronchodilating compositions and methods of use thereof
|
|
WO2003006310A1
(fr)
|
2001-07-13 |
2003-01-23 |
Tfe Techniques Et Fabrications Electroniques |
Dispositif destine a indiquer acoustiquement a un plongeur equipe d'un scaphandre la pression de gaz de respiration dans le reservoir et/ou la pression hydrostatique
|
|
WO2003035030A1
(en)
|
2001-10-24 |
2003-05-01 |
Pari Gmbh |
Kit for the preparation of a pharmaceutical composition
|
|
KR20050044503A
(ko)
|
2001-11-17 |
2005-05-12 |
아벤티스 파마 리미티드 |
흡착제 및 이의 용도
|
|
US20050020637A1
(en)
|
2001-11-19 |
2005-01-27 |
Wolfgang-Alexander Simon |
Agents for the treatment of airway disorders
|
|
GB0207899D0
(en)
*
|
2002-04-05 |
2002-05-15 |
3M Innovative Properties Co |
Formoterol and cielesonide aerosol formulations
|
|
ITMI20020808A1
(it)
|
2002-04-17 |
2003-10-17 |
Chiesi Farma Spa |
Procedimento per la preparazione di una sospensione sterile di particelle di beclometasone dipropionato da somministrare per inalazione
|
|
RS57455B1
(sr)
|
2002-07-02 |
2018-09-28 |
Astrazeneca Ab |
Sterilna vodena suspenzija koja sadrži ciklezonid
|
|
WO2004019955A1
(en)
|
2002-08-30 |
2004-03-11 |
Altana Pharma Ag |
The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
|
|
JP2006528228A
(ja)
|
2003-05-22 |
2006-12-14 |
アルタナ ファルマ アクチエンゲゼルシャフト |
サルメテロール及びシクレソニドの組合せ物
|
|
GB0312148D0
(en)
|
2003-05-28 |
2003-07-02 |
Aventis Pharma Ltd |
Stabilized pharmaceutical products
|
|
EP1635845A1
(en)
|
2003-06-13 |
2006-03-22 |
ALTANA Pharma AG |
Formoterol and ciclesonide combination
|
|
GB0315889D0
(en)
|
2003-07-08 |
2003-08-13 |
Aventis Pharma Ltd |
Stable pharmaceutical products
|
|
EP1670482B2
(en)
|
2003-09-16 |
2022-06-29 |
Covis Pharma B.V. |
Use of ciclesonide for the treatment of respiratory diseases
|